WeChat Mini Program
Old Version Features

Cost-effectiveness Analysis of Eribulin Versus Dacarbazine in Patients with Advanced Liposarcoma

Miaomiao Zhang, Jinlong Huang,Xiaochun Zheng,Ping Huang,Xiuli Yang

Scientific Reports(2025)

Cited 0|Views0
Key words
Cost-effectiveness,Advanced liposarcoma,Eribulin,Dacarbazine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined